ClinicalTrials.Veeva

Menu

Ultra Long-Term Sleep Monitoring Using UNEEG™ Medical 24/7 EEG™ SubQ (ULTS)

U

UNEEG medical

Status

Completed

Conditions

Sleep

Treatments

Diagnostic Test: 24/7 EEG™ SubQ

Study type

Interventional

Funder types

Other
Industry

Identifiers

Details and patient eligibility

About

This study aims to evaluate the agreement between automated sleep analysis by UNEEG medical's 24/7 EEG™ SubQ device using a deep learning algorithm and the consensus score of multiple sleep technologists' manual scoring of 120 gold-standard polysomnograms (PSG) from healthy subjects.

Full description

The aim of the study is to evaluate the agreement between automated sleep analysis by UNEEG medical's 24/7 EEG™ SubQ device using a deep learning algorithm and the consensus score of multiple sleep technologists' manual scoring of 120 gold-standard polysomnograms (PSG).

The study will enroll 20 healthy subjects who will wear the UNEEG™ SubQ device for 365 consecutive nights. All subjects are prescreened and invited to an interview to confirm eligibility. Subjects who provide informed consent are enrolled and will complete a detailed demographic, medical, health, sleep, and lifestyle survey. The enrolled subjects will have the UNEEG™ SubQ implanted and after approximately 10 days of healing the study subjects will start wearing the external part of the 24/7 EEG™ SubQ. Throughout the study the subjects will wear an ActiGraph, fill out a sleep diary and conduct cognitive tests. The duration of the study from screening to removal of sutures will be approximately 58 weeks.

Enrollment

25 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Age ≥18 years
  • Subjects must be of general good health

Exclusion criteria

  • Has cochlear implants.
  • Involved in therapies with medical devices that deliver electrical energy into the area around the implant
  • Is at high risk of surgical complications, such as active systemic infection and hemorrhagic disease.
  • Are unable (i.e. mentally or physically impaired patient), or do not have the necessary assistance, to properly operate the device system.
  • Has an infection at the site of device implantation.
  • Operates MRI scanners.
  • Has a profession/hobby that includes activity imposing extreme pressure variations (e.g. diving or parachute jumping). N.B.: diving/snorkeling is allowed to 5 meters depth.
  • Has a profession/hobby that includes activity imposing an unacceptable risk for trauma against the device or the site of implantation (e.g. martial art or boxing).
  • Previous stroke or cerebral hemorrhage and any other structural cerebral disease.
  • Ongoing or history of sleep disorders.
  • Known neurological diseases.
  • Known or suspected abuse of alcohol defined as estimated consumption beyond that, which is recommended by the Danish Health Authority or any other neuro-active substances.
  • Other known diseases or conditions, judged by investigator to influence sleep to such a degree that data quality will be compromised.
  • Medication judged by investigator to influence sleep to such a degree that data quality will be compromised.
  • Incapable, judged by the investigator, of understanding the participant instruction or who are not capable of carrying through the investigation.
  • Pregnancy or intention to become pregnant within the next 12 months.

Trial design

Primary purpose

Diagnostic

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

25 participants in 1 patient group

Healthy adults
Experimental group
Description:
UNEEG™ medical 24/7 EEG™ SubQ
Treatment:
Diagnostic Test: 24/7 EEG™ SubQ

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems